APA

MacManus D. G., Miller D. H., Kappos L., Gold R., Havrdova E., Limmroth V., Polman C. H., Schmierer K., Yousry T. A., Eraksoy M., Meluzinova E., Dufek M., Yang M., O'Neill G. N. & Dawson K. (20120109). BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. : Journal of neurology.

Chicago

MacManus D G, Miller D H, Kappos L, Gold R, Havrdova E, Limmroth V, Polman C H, Schmierer K, Yousry T A, Eraksoy M, Meluzinova E, Dufek M, Yang M, O'Neill G N and Dawson K. 20120109. BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. : Journal of neurology.

Harvard

MacManus D. G., Miller D. H., Kappos L., Gold R., Havrdova E., Limmroth V., Polman C. H., Schmierer K., Yousry T. A., Eraksoy M., Meluzinova E., Dufek M., Yang M., O'Neill G. N. and Dawson K. (20120109). BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. : Journal of neurology.

MLA

MacManus D G, Miller D H, Kappos L, Gold R, Havrdova E, Limmroth V, Polman C H, Schmierer K, Yousry T A, Eraksoy M, Meluzinova E, Dufek M, Yang M, O'Neill G N and Dawson K. BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. : Journal of neurology. 20120109.